Kezar Life Sciences, Inc.KZRNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-56.66M
↓ 33% vs avg
Percentile
P33
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-42.55M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-56.66M | +23.7% |
| 2024 | $-74.24M | +11.0% |
| 2023 | $-83.45M | -38.1% |
| 2022 | $-60.42M | -41.3% |
| 2021 | $-42.75M | -15.1% |
| 2020 | $-37.14M | -21.8% |
| 2019 | $-30.48M | -39.1% |
| 2018 | $-21.91M | -157.8% |
| 2017 | $-8.50M | +14.1% |
| 2016 | $-9.89M | - |